Floriana Morgillo

Floriana Morgillo

Naples, 80138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 163 publications

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993.

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993.

Journal: Journal of personalized medicine

Published: June 26, 2026

RAS Inhibitors: Changing the Paradigm from the Undruggable.

RAS Inhibitors: Changing the Paradigm from the Undruggable.

Journal: Pharmaceutics

Published: April 30, 2026

When Lymph Nodes Don't Lie: Report of Three Unusual Presentations of Thoracic Tumors.

When Lymph Nodes Don't Lie: Report of Three Unusual Presentations of Thoracic Tumors.

Journal: Diagnostics (Basel, Switzerland)

Published: February 26, 2026

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability.

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability.

Journal: Exploration of targeted anti-tumor therapy

Published: December 30, 2025

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

Journal: Journal of clinical medicine

Published: November 23, 2025

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Journal: Translational oncology

Published: October 14, 2025

Prevailing challenges in companion diagnostic test development for lung cancer.

Prevailing challenges in companion diagnostic test development for lung cancer.

Journal: Expert review of anticancer therapy

Published: October 11, 2025

Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

Journal: Oncotarget

Published: August 29, 2025

High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice.

High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice.

Journal: Histopathology

Published: August 20, 2025

Correction: Understanding the role of the gut microbiome in gastrointestinal cancer: A review.

Correction: Understanding the role of the gut microbiome in gastrointestinal cancer: A review.

Journal: Frontiers in pharmacology

Published: July 09, 2025

Showing 1-12 of 163

Last Updated: 09/26/2026